Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-18-005891
Filing Date
2018-08-09
Accepted
2018-08-09 06:31:50
Documents
52
Period of Report
2018-08-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_080918.htm 6-K 9445
2 EXHIBIT 99.1 exh_991.htm EX-99.1 182437
3 EXHIBIT 99.2 exh_992p.htm EX-99.2 346686
10 GRAPHIC fs_graphic.jpg GRAPHIC 26769
  Complete submission text file 0001171843-18-005891.txt   3135241

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE cmta-20180630.xml EX-101.INS 610882
5 XBRL SCHEMA FILE cmta-20180630.xsd EX-101.SCH 52228
6 XBRL CALCULATION FILE cmta-20180630_cal.xml EX-101.CAL 29951
7 XBRL DEFINITION FILE cmta-20180630_def.xml EX-101.DEF 217330
8 XBRL LABEL FILE cmta-20180630_lab.xml EX-101.LAB 216420
9 XBRL PRESENTATION FILE cmta-20180630_pre.xml EX-101.PRE 236484
Mailing Address 4150 ST CATHERINE STREET WEST SUITE 550 MONTREAL A8 H3Z 2Y5
Business Address 4150 ST CATHERINE STREET WEST SUITE 550 MONTREAL A8 H3Z 2Y5 (514) 940-3600
Clementia Pharmaceuticals Inc. (Filer) CIK: 0001647320 (see all company filings)

EIN.: 981128564 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38177 | Film No.: 181003114
SIC: 2834 Pharmaceutical Preparations